Skip to main content

Advertisement

Log in

Is radical radiotherapy effective in patients with pT1G3 NXM0 bladder cancer?

  • Practice Point
  • Published:

From Nature Clinical Practice Urology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Herr HW (2005) Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette–Guerin therapy. J Urol 174: 2134–2137

    Article  Google Scholar 

  2. Cookson MS et al. (1997) The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158: 62–67

    Article  CAS  Google Scholar 

  3. Herr HW et al. (2007) Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy. J Urol 177: 75–79

    Article  Google Scholar 

  4. Raj GV et al. (2007) Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol 177: 1283–1286

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herr, H. Is radical radiotherapy effective in patients with pT1G3 NXM0 bladder cancer?. Nat Rev Urol 5, 22–23 (2008). https://doi.org/10.1038/ncpuro0976

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0976

  • Springer Nature Limited

Navigation